As reported in Materials and Methods, the nine control and the seven FSHD cell lines showed a highly comparable extent of Desmin-positive cells and of myogenic markers modulation upon differentiation (Fig. S1). The gene discussed is DES; the disease is facioscapulohumeral muscular dystrophy.